Literature DB >> 7967983

Gynaecological monitoring during tamoxifen therapy.

D Bissett1, J A Davis, W D George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7967983     DOI： 10.1016/s0140-6736(94)90747-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

2.  Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.

Authors:  Yoshihiko Ino; Taishi Akimoto; Akira Takasawa; Kumi Takasawa; Tomoyuki Aoyama; Asako Ueda; Misaki Ota; Kazufumi Magara; Yohei Tagami; Masaki Murata; Tadashi Hasegawa; Tsuyoshi Saito; Norimasa Sawada; Makoto Osanai
Journal:  Histol Histopathol       Date:  2019-09-04       Impact factor: 2.303

3.  Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.

Authors:  Kassondra S Grzankowski; J Brian Szender; Chandra L Spring-Robinson; Shashikant B Lele; Kunle O Odunsi; Peter J Frederick
Journal:  Int J Gynecol Cancer       Date:  2016-10       Impact factor: 3.437

Review 4.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

5.  Long-term safety of aromatase inhibitors in the treatment of breast cancer.

Authors:  Jean-Marc A Nabholtz
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

Review 6.  Breast cancer metastasising to the uterine cervix.

Authors:  C A Bryson; R H de Courcy-Wheeler; R J Wallace
Journal:  Ulster Med J       Date:  1999-05

Review 7.  Enriching Personalized Endometrial Cancer Research with the Harmonization of Biobanking Standards.

Authors:  Meera Adishesh; Dharani K Hapangama
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

8.  Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.

Authors:  Taishi Akimoto; Akira Takasawa; Kumi Takasawa; Tomoyuki Aoyama; Masaki Murata; Makoto Osanai; Tsuyoshi Saito; Norimasa Sawada
Journal:  Neoplasia       Date:  2018-09-15       Impact factor: 5.715

Review 9.  Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles.

Authors:  Candace M Day; Shane M Hickey; Yunmei Song; Sally E Plush; Sanjay Garg
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.